本文报道我院近来收治的180例原发性癫痫患者的治疗效果,全部病例随机分为三组,分别用苯妥英钠、中枢性抗胆碱药(安坦、东莨菪碱)和中枢性抗胆碱药加r—氨酪酸治疗。结果表明三组治愈率分别为18%(9/50)、38%(23/60P<0.05)和43%(30/70,P<0.01);好转率分别为32%(16/50)57%(34/60,P<0.05)和53%(37/70,P<0.05)。提示,用中枢性抗胆碱药治疗原发性癫痫效果优于苯妥安钠,中枢性抗胆碱药加r—氨酪酸优于单纯中枢性抗胆碱药。 This article reports the treatment of 180 cases of patients with primary epilepsy treated recently in our hospital, all cases were randomly divided into three groups, respectively, with phenytoin sodium, central anticholinergic (Antan, scopolamine) and central anticholinergic plus r- . The results showed that the cure rates of the three groups were 18% (9/50), 38% (23/60 P <0.05) and 43% (30/70, P <0.01) % (34/60, P <0.05) and 53% (37/70, P <0.05). Tip, with central anticholinergic treatment of primary epilepsy better than phenytoin, central anticholinergic plus r-aminobutyric acid is superior to simple central anticholinergic.